Results 11 to 20 of about 88,050 (335)
ASPIRIN RESISTANCE IN NEUROVASCULAR DISEASES [PDF]
Acta Medica, 2014 Introduction: The issue of resistance to antiplatelet therapy has raised many questions in the area of neurovascular diseases. The first objective of this work was to determine the prevalence of aspirin resistance in neurovascular patients with clinical ...
Martin Vališ +6 more
doaj +4 more sources
Factors associated with aspirin resistance in diabetic patients: A metabolic and inflammatory profile analysis. [PDF]
PLoS ONEBackgroundDiabetes mellitus (DM) is strongly linked to both first-time and recurrent atherosclerotic thrombotic events. Although aspirin (ASA) is commonly used to prevent cardiovascular diseases, studies have shown that ASA does not significantly reduce ...
Bo Chen +5 more
doaj +2 more sources
The association between aspirin resistance and extent and severity of coronary atherosclerosis [PDF]
İstanbul Kuzey Klinikleri, 2018 INTRODUCTION[|]Uncontrolled inflammatory responses could contribute to the pathogenesis of many leading causes of human morbidity and mortality. Aspirin is an anti-inflammatory and antithrombotic drug that is used in the primary and secondary protection ...
Serkan Kahraman +5 more
doaj +2 more sources
Aspirin Resistance and Compliance with Therapy [PDF]
Cardiovascular Therapeutics, 2010 Aspirin resistance is associated with increased cardiovascular risk in aspirin-treated patients. Poor compliance may explain many cases of "resistance," yet few clinical studies have used objective measurement of therapy compliance. We did so in a case-controlled study.We enrolled patients within 24 h of ischemic stroke and a group of controls taking ...
Jesse Dawson +6 more
openalex +4 more sources
ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
Кардиоваскулярная терапия и профилактика, 2013 The review presents the current literature evidence on the most likely genetic polymorphisms of aspirin resistance, such as polymorphisms of cyclooxygenase, glycoproteins GP Ib/IIIa, GP Ibα, GP VI, and adenosine diphosphate receptors P2Y1 and P2Y12.
Yu. I. Grinshtein +2 more
doaj +3 more sources
Aspirin-Resistenz / Aspirin resistance [PDF]
LaboratoriumsMedizin, 2006 Thomas Hohlfeld
openalex +3 more sources
The prevalence and associated factors of aspirin resistance among prophylactic aspirin users [PDF]
Romanian Journal of Neurology, 2021 Background. Aspirin is an antiplatelet used for the secondary prevention after vascular events. It is also suggested for the primary prevention of vascular events in high risk people, however, despite using standard prophylactic doses, aspirin resistance
Samaneh Ghorbani-Shirkouhi +5 more
doaj +1 more source
Journal of Thrombosis and Haemostasis, 2005 Treatment failures occur with any drug and aspirin is no exception. Evidence is growing to indicate that there are subpopulations that do not respond to antithrombotic action of aspirin. The term 'aspirin resistance' has been used to describe a number of different phenomena, including inability of aspirin to: (i) protect against cardiovascular events ...
J. Musiał +3 more
openaire +3 more sources
Прогностическое значение аспиринорезистентности при ишемической болезни сердца [PDF]
, 2008 Рассмотрены данные литературы о значении аспиринорезистентности при ИБС. Предложен разработанный авторами новый экспресс−метод определения чувствительности к аспирину.
Adolescent development: Characteristics and determinants +11 more
core +5 more sources
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. [PDF]
, 2006 BACKGROUND AND PURPOSE: Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; however, it is not known whether the recent increased use of ...
Byrne, Michael F +5 more
core +1 more source